Stock Screener App

無料 -

インストール

13.55

2.87% -0.40

after-market

アフターアワーズ： 13.55

Lyell Immunopharma Inc (LYEL)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Lyell Immunopharma Inc (LYEL) 財務データ

*すべての数値は百万単位です

期間終了日	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	87.50% 0.015	0.008	0.007	0.011	0.034
Operating Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Operating Income/Loss	20.97% -37.25	-47.14	-57.37	-201.15	-50.51
Nonoperating Income/Loss	135.75% -1.593	4.456	5.172	9.212	5.922
Income/Loss From Continuing Operations Before Tax	87.50% 0.015	0.008	0.007	0.011	0.034
Income/Loss From Continuing Operations After Tax	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Net Income/Loss	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Diluted Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Basic Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Diluted Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$64.46

1.80%

ROIV

$36.24

0.11%

RPRX

$59.45

1.45%

INSM

$128.32

3.70%

ALNY

$224.60

1.77%

ONC

$362.51

4.33%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く